<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
  <title>Mavengity</title>
  <link>https://mavengity.com/</link>
  <description>Independent news and education on insurance, mortgages, personal finance, legal, healthcare, and B2B research.</description>
  <language>en-us</language>
  <lastBuildDate>Thu, 10 Sep 2026 12:37:39 +0000</lastBuildDate>
  <image>
    <url>https://mavengity.com/assets/img/mavengity-yt-logo.png</url>
    <title>Mavengity</title>
    <link>https://mavengity.com/</link>
  </image>
  <item>
    <title>Bank Regulators Just Defined What Unsafe and Unsound Means</title>
    <link>https://mavengity.com/articles/finance/fdic-occ-define-unsafe-unsound/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/finance/fdic-occ-define-unsafe-unsound/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>finance</category>
    <description>The FDIC and OCC have finalized the first regulatory definition of an &quot;unsafe or unsound practice,&quot; and it deliberately leaves reputation risk out.</description>
  </item>
  <item>
    <title>The $10,000 Car Loan Interest Deduction Just Got Its Rulebook</title>
    <link>https://mavengity.com/articles/finance/irs-car-loan-interest-deduction-final-rule/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/finance/irs-car-loan-interest-deduction-final-rule/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>finance</category>
    <description>Final Treasury rules published Monday spell out which vehicles, loans and borrowers qualify for the new deduction, and they put lenders on the hook for reporting.</description>
  </item>
  <item>
    <title>A Growth Drug Passed Its Pivotal Test in a Second Bone Condition</title>
    <link>https://mavengity.com/articles/healthcare-medical/biomarin-voxzogo-hypochondroplasia-phase-3/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/healthcare-medical/biomarin-voxzogo-hypochondroplasia-phase-3/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>healthcare-medical</category>
    <description>Detailed Phase III results for Voxzogo in hypochondroplasia showed a 2.33 centimeter annual growth velocity advantage, published in NEJM Evidence.</description>
  </item>
  <item>
    <title>The First Survival Win for a BiTE Drug Arrives in Small Cell Lung Cancer</title>
    <link>https://mavengity.com/articles/healthcare-medical/imfinzi-imdelltra-dellphi-305-small-cell-lung-cancer/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/healthcare-medical/imfinzi-imdelltra-dellphi-305-small-cell-lung-cancer/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>healthcare-medical</category>
    <description>AstraZeneca and Amgen&apos;s DeLLphi-305 trial showed Imfinzi plus Imdelltra improved overall survival in extensive-stage small cell lung cancer.</description>
  </item>
  <item>
    <title>The $12 Billion Muscle Drug Missed Its Big Test</title>
    <link>https://mavengity.com/articles/healthcare-medical/novartis-del-desiran-dm1-harbor-miss/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/healthcare-medical/novartis-del-desiran-dm1-harbor-miss/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>healthcare-medical</category>
    <description>Novartis&apos; del-desiran failed its Phase III endpoint in myotonic dystrophy type 1, a setback for the centerpiece of the Avidity Biosciences acquisition.</description>
  </item>
  <item>
    <title>An Oral Drug Cut HAE Attacks by 83 Percent in a Pivotal Trial</title>
    <link>https://mavengity.com/articles/healthcare-medical/pharvaris-deucrictibant-hae-chapter-3/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/healthcare-medical/pharvaris-deucrictibant-hae-chapter-3/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>healthcare-medical</category>
    <description>Pharvaris&apos; deucrictibant extended-release tablets met the primary endpoint of the CHAPTER-3 study, including in the HAE subgroup with no dedicated prophylactic option.</description>
  </item>
  <item>
    <title>Imran Ahmed&apos;s Deportation Fight Now Rests on Five Business Days</title>
    <link>https://mavengity.com/articles/legal/imran-ahmed-deportation-five-business-days/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/legal/imran-ahmed-deportation-five-business-days/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>legal</category>
    <description>A federal judge dismissed the British activist&apos;s lawsuit challenging his potential deportation, while keeping a temporary restraining order alive long enough for an appeal.</description>
  </item>
  <item>
    <title>A Court Counted 42,695 Unlawful Disclosures in the IRS-ICE Data Pipeline</title>
    <link>https://mavengity.com/articles/legal/irs-ice-tax-data-court-counts-42695/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/legal/irs-ice-tax-data-court-counts-42695/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>legal</category>
    <description>The D.C. Circuit has upheld an injunction against the IRS sharing taxpayer addresses with immigration authorities, and the opinion reads like an audit of a data handoff gone wrong.</description>
  </item>
  <item>
    <title>One Louisiana Case Could Decide How Abortion Pills Reach Every State</title>
    <link>https://mavengity.com/articles/legal/louisiana-mifepristone-telehealth-fifth-circuit/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/legal/louisiana-mifepristone-telehealth-fifth-circuit/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>legal</category>
    <description>The Fifth Circuit heard arguments Tuesday in Louisiana v. FDA, a challenge that seeks to end telehealth prescribing and mailed mifepristone nationwide.</description>
  </item>
  <item>
    <title>The Map That Never Existed Now Decides Missouri&apos;s Election</title>
    <link>https://mavengity.com/articles/legal/missouri-map-that-never-existed/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/legal/missouri-map-that-never-existed/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>legal</category>
    <description>Hours after the Supreme Court declined to intervene, a federal judge ordered Missouri to use a congressional map its own state supreme court says never took effect, leaving election officials caught between two orders.</description>
  </item>
  <item>
    <title>Missouri&apos;s Secretary of State Must Answer to Two Courts at Once</title>
    <link>https://mavengity.com/articles/legal/missouri-secretary-of-state-two-courts/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/legal/missouri-secretary-of-state-two-courts/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>legal</category>
    <description>The state Supreme Court has opened a contempt probe into Denny Hoskins over the congressional map fight, while a federal judge keeps ordering him to use that same map.</description>
  </item>
  <item>
    <title>Washington Accuses Six Chinese AI Firms of Industrial-Scale Copying</title>
    <link>https://mavengity.com/articles/legal/us-advisory-six-chinese-ai-firms-distillation/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/legal/us-advisory-six-chinese-ai-firms-distillation/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate>
    <category>legal</category>
    <description>A joint FBI, NSA and CISA advisory names DeepSeek, Alibaba and four others, alleging billions of tokens were extracted from American frontier models.</description>
  </item>
  <item>
    <title>Australia&apos;s Surcharge Ban Pushes the Cost of Cards Onto Rewards Holders</title>
    <link>https://mavengity.com/articles/finance/australia-surcharge-ban-cost-moves-to-rewards-holders/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/finance/australia-surcharge-ban-cost-moves-to-rewards-holders/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate>
    <category>finance</category>
    <description>From October 1 Australian businesses cannot add card surcharges, and the Reserve Bank is cutting interchange fees to pay for it. The cost is moving, not disappearing, and the first bill has landed on rewards cards.</description>
  </item>
  <item>
    <title>California Draws the Line Between an AI Assistant and a Therapist</title>
    <link>https://mavengity.com/articles/healthcare-medical/california-line-between-ai-assistant-and-therapist/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/healthcare-medical/california-line-between-ai-assistant-and-therapist/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate>
    <category>healthcare-medical</category>
    <description>California&apos;s pending SB 903 would ban unlicensed AI therapy and restrict how licensed professionals use AI with patients. The bill&apos;s principle is that what matters is the conduct, not what the app calls itself.</description>
  </item>
  <item>
    <title>Europe&apos;s Biotech Act Promises Faster Trials the EU Has Never Managed</title>
    <link>https://mavengity.com/articles/healthcare-medical/eu-biotech-act-faster-trials-ema-report/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/healthcare-medical/eu-biotech-act-faster-trials-ema-report/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate>
    <category>healthcare-medical</category>
    <description>The European Commission wants clinical trial authorization cut from about 106 days to 75. The EU&apos;s first progress report on its 2030 trial targets shows why the Act exists: the continent&apos;s trial machine is running behind its own goals.</description>
  </item>
  <item>
    <title>A Comparison Site Compared Two Insurers and Called It the Market</title>
    <link>https://mavengity.com/articles/insurance/choosi-two-insurers-called-it-the-market/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/insurance/choosi-two-insurers-called-it-the-market/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate>
    <category>insurance</category>
    <description>An Australian Federal Court has found comparison site Choosi misled customers by claiming to survey a range of insurers while overwhelmingly comparing policies from one. The ruling draws a legal line around the word range.</description>
  </item>
  <item>
    <title>Australia Lets Users Switch Off the Feed and the Platforms Still Choose the Default</title>
    <link>https://mavengity.com/articles/legal/australia-algorithm-opt-out-default-is-the-debate/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/legal/australia-algorithm-opt-out-default-is-the-debate/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate>
    <category>legal</category>
    <description>Australia&apos;s My Feed, My Way bill would force social platforms to offer users a real choice over algorithmic feeds. The fight is not over the opt-out; it is over which feed the platform is allowed to make the default.</description>
  </item>
  <item>
    <title>The False Claims Act&apos;s Whistleblower Engine Survives Its Constitutional Test</title>
    <link>https://mavengity.com/articles/legal/fca-qui-tam-constitutional-test-eleventh-circuit/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/legal/fca-qui-tam-constitutional-test-eleventh-circuit/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate>
    <category>legal</category>
    <description>An appeals court has ruled that private citizens who sue fraudsters on the government&apos;s behalf are not constitutional officers, reversing the ruling that threatened the False Claims Act&apos;s enforcement machine. The bigger fight is now headed toward the Supreme Court.</description>
  </item>
  <item>
    <title>Oklahoma&apos;s Proxy Adviser Law Arrives Where Three Other States Already Lost</title>
    <link>https://mavengity.com/articles/legal/oklahoma-proxy-adviser-law-three-losses-one-more/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/legal/oklahoma-proxy-adviser-law-three-losses-one-more/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate>
    <category>legal</category>
    <description>ISS is asking a federal court to block Oklahoma&apos;s Proxy Advisor Transparency Act before it takes effect November 1. The law requires written financial analysis for any recommendation against management, and the same model has already failed in three states.</description>
  </item>
  <item>
    <title>The AI-Native Banking Launch That Is Mostly Plumbing</title>
    <link>https://mavengity.com/articles/finance/ai-native-launch-that-is-mostly-plumbing/</link>
    <guid isPermaLink="true">https://mavengity.com/articles/finance/ai-native-launch-that-is-mostly-plumbing/</guid>
    <pubDate>Mon, 07 Sep 2026 00:00:00 +0000</pubDate>
    <category>finance</category>
    <description>People First Bank&apos;s new digital platform carries an AI-native label, but what shipped is more interesting: unified channels over an old core and the mutual&apos;s first fully digital onboarding.</description>
  </item>
</channel>
</rss>
